- Citations, last 5 years
- 680
- Works, last 5 years
- 184
- h-index
- 83
- Scientists listed
- 13
- Grants since 2016
- 1 402
Grants received
2019–2022 · fellowship · F31
Advanced Recombinase Technology for Tissue Engineering Applications
Justin Henry Letendre · Charles River Associates · funded by National Institutes of Health
2019–2022 · fellowship · F31
Advanced Recombinase Technology for Tissue Engineering Applications
Justin Henry Letendre · Charles River Associates · funded by National Institutes of Health
2019–2024 · program · P50
Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder
Connie L. Kasari · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
ePACE: an automated system for high-throughput, closed-loop control of continuous molecular evolution to enable novel therapeutics
Ahmad Samir Khalil · Charles River Associates · funded by National Institutes of Health
2019–2024 · training · T32
Synthetic Biology and Biotechnology (SB2) Predoctoral Training Program
Christopher S Chen · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
Growth Hormone Regulation of Sex Differences in Liver Metabolism
David J Waxman · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
Multiplexed Imaging in the Near Infrared with Indium Phosphide Quantum Shells
Allison Marie Dennis · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
Neural circuits for regulating social behavior in rodents
Ian Gordon Davison · Charles River Associates · funded by National Institutes of Health
2019–2021 · research · R00
Imaging neural dynamics at high temporal resolution in sleep and sleep deprivation
Laura Diane Lewis · Charles River Associates · funded by National Institutes of Health
2019–2022 · research · R01
Optimizing and Learning Strategies for Protein Docking
Pirooz Vakili · Charles River Associates · funded by National Institutes of Health
2019–2022 · cooperative agreement · UH3
Internet-Based Video-Conferencing to Address Alcohol Use and Pain Among Heavy Drinkers in HIV-Care
Tibor P. Palfai · Charles River Associates · funded by National Institutes of Health
2019–2022 · fellowship · F31
Voltage imaging of striatal neuron activity during movement
Sanaya Ness Shroff · Charles River Associates · funded by National Institutes of Health
2019–2023 · fellowship · F31
Working Memory in Preclinical Alzheimer's Disease: a Neuropsychological and Neuroimaging Investigation
Joshua Thomas Fuller · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
ePACE: an automated system for high-throughput, closed-loop control of continuous molecular evolution to enable novel therapeutics
Ahmad Samir Khalil · Charles River Associates · funded by National Institutes of Health
2019–2029 · research · R01
Organization and Circuit Interactions of Thalamocortical Attentional Networks in Health and Disease
Arash Yazdanbakhsh · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
A Comprehensive Resource for Escherichia coli Genomic Data and Tools
Julio Collado-Vides · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
Organization and Circuit Interactions of Thalamocortical Attentional Networks in Health and Disease
Arash Yazdanbakhsh · Charles River Associates · funded by National Institutes of Health
2019–2021 · research · R56
Engineering a smart CAR platform for human regulatory T cells
Hans Peter Dooms · Charles River Associates · funded by National Institutes of Health
2019–2022 · research · R00
Imaging neural dynamics at high temporal resolution in sleep and sleep deprivation
Laura Diane Lewis · Charles River Associates · funded by National Institutes of Health
2019–2024 · program · P50
Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder
Connie L. Kasari · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R00
Development of In Vitro Compression-Induced Rotator Cuff Injury Model: Aging and Inflammation in Tendon Degeneration
Brianne Kathryn Connizzo · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2019–2021 · research · R21
Focal ultrasound-mediated nonthermal ablation of brain tumors
Tyrone Porter · Charles River Associates · funded by National Institutes of Health
2019–2022 · fellowship · F32
Eye Movements and the Dynamics of Adaptive Learning
Leah Bakst · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
Notch signaling and adhesion regulation
Christopher S Chen · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
Understanding the fast and slow spatiotemporal dynamics of human seizures
Sydney S Cash · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
Optimizing and Learning Strategies for Protein Docking
Pirooz Vakili · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
SCH: INT: Collaborative Research: Passive sensing of social isolation: A digital phenotying approach
Carlos Alberto Busso · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2019–2024 · research · R01
Improving Working Memory in Older Adults by Restoring Large-Scale Cortical Interactions
Robert Reinhart · Charles River Associates · funded by National Institutes of Health
2019–2025 · research · R01
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2019–2021 · research · R21
Focal ultrasound-mediated nonthermal ablation of brain tumors
Tyrone Porter · Charles River Associates · funded by National Institutes of Health
2019–2021 · fellowship · F31
Elucidating the Mechanism of B-Raf Dimerization Inhibition Using (+)-Griffipavixanthone Derivatives
Michael J Smith · Charles River Associates · funded by National Institutes of Health
2019–2022 · fellowship · F32
Eye Movements and the Dynamics of Adaptive Learning
Leah Bakst · Charles River Associates · funded by National Institutes of Health
2019–2021 · fellowship · F31
Behavioral and Neural Effects of Intensive Cognitive-Communication Rehabilitation in Young College-Bound Adults with Acquired Brain Injury
Natalie Gilmore · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
SCH: Multimodal,Task-Aware Movement Assessment and Control: Clinic to Home
Louis N Awad · Charles River Associates · funded by National Institutes of Health
2019–2023 · research · R01
Multiplexed Imaging in the Near Infrared with Indium Phosphide Quantum Shells
Allison Marie Dennis · Charles River Associates · funded by National Institutes of Health
2019–2022 · research · R01
Multiplexed Imaging in the Near Infrared with Indium Phosphide Quantum Shells
Allison Marie Dennis · Charles River Associates · funded by National Institutes of Health